Market Overview

A Peek Into The Market Before The Trading Starts

A Peek Into The Market Before The Trading Starts
Related MGM
Las Vegas Strip Gambling Sales Fall In December, Gaming Stocks Tumble
Macau Gaming Stocks Pop After Analysts Suggest It's Time To 'Get Back In'
Weak report on Las Vegas revenue trips up gaming sector (Seeking Alpha)
Related FDP
Fresh Del Monte Produce Announces Preliminary Results Of Its Modified Dutch Auction Tender Offer
Earnings Scheduled For October 28, 2014

Pre-open movers US stock futures are higher this morning, as investors are awaiting housing market index. Futures for the Dow Jones Industrial Average surged 21 points to 13,969.00 and S&P 500 index futures rose 1.30 points to 1,518.40. Nasdaq 100 futures climbed 2.50 points to 2,763.75.

A Peek Into Global Markets European markets were higher today. The STOXX Europe 600 Index rose 0.61%, London's FTSE 100 Index gained 0.29%, German DAX 30 Index rose 0.79% and French CAC 40 Index climbed 1.10%.

Asian markets ended mixed, with Japan's Nikkei Stock Average falling 0.31%, China's Shanghai Composite dropping 1.60% and Australia's S&P/ASX 200 Index gaining 0.36%. Hong Kong's Hang Seng Index fell 1.02% and India's Sensex gained 0.69%.

Broker Recommendation Analysts at RBC Capital upgraded MGM Resorts International (NYSE: MGM) from “sector perform” to “outperform.” The target price for MGM Resorts has been raised from $13 to $16.

MGM Resorts shares gained 0.16% to $12.90 in pre-market trading.

Breaking news

  • Fresh Del Monte Produce (NYSE: FDP) reported a break-even profit for the fourth quarter. To read the full news, click here.
  • Today, Microsoft (NASDAQ: MSFT) announced that its highly popular email service,, is ready for primetime. To read the full news, click here.
  • Westlake Chemical (NYSE: WLK) reported a surge in its fourth-quarter profit. To read the full news, click here.
  • Regeneron Pharmaceuticals (NASDAQ: REGN) and Bayer HealthCare today announced that they have initiated a new Phase 3 trial to evaluate the efficacy and safety of EYLEA® (aflibercept) Injection in the treatment of Diabetic Macular Edema (DME) in Russia, China, and other Asian countries. To read the full news, click here.

Posted-In: RBC Capital US Stock FuturesNews Futures Global Pre-Market Outlook Markets


Related Articles (FDP + MGM)

Around the Web, We're Loving...

Get Benzinga's Newsletters